Literature DB >> 15631921

Leiomyosarcoma of the retrohepatic portion of the inferior vena cava: clinical presentation and surgical management in five patients.

Jean Hardwigsen1, Paul Balandraud, Pascal Ananian, Jean Saïsse, Y Patrice Le Treut.   

Abstract

BACKGROUND: Leiomyosarcoma (LMS) is a rare primary soft tissue sarcoma arising from the inferior vena cava (IVC). For LMS involving the retrohepatic portion of IVC there are limited published data about tumor features, surgical strategies, and IVC replacement. STUDY
DESIGN: Clinical data, surgical procedures, and pathologic features of five consecutive patients referred for IVC-LMS, in 5 years, were reviewed. A complete surgical resection of the tumor was performed in each patient and IVC replacement used expanded polytetrafluoroethylene grafts.
RESULTS: Abdominal pain (n = 4) and palpable flank mass (n = 3) were the most frequent signs. To assure a complete tumoral exeresis, adjacent organ resection included hepatectomy (n = 4), extended right nephrectomy (n = 3), and right adrenalectomy (n = 1). Prosthetic IVC reconstruction was performed in four patients, three times associated with arteriovenous fistula. Median postoperative stay was 18 days. No prosthetic-related complication was observed, venous insufficiency sequela did not occur. Tumoral clearance was achieved in all patients, and direct tumoral involvement of the liver was less frequent than for kidney. Three patients died at a median followup of 34 months, two are alive and disease-free at 34 and 44 months.
CONCLUSIONS: LMS of the IVC is characterized by locally advanced status at the time of diagnosis. A radical tumoral resection associated with liberal use of venous prosthetic replacement may offer a chance for cure and good quality of life in palliative situations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15631921     DOI: 10.1016/j.jamcollsurg.2004.09.035

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  8 in total

1.  Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.

Authors:  Daniel Azoulay; Paola Andreani; Umberto Maggi; Chadi Salloum; Fabiano Perdigao; Mylène Sebagh; Antoinette Lemoine; René Adam; Denis Castaing
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava.

Authors:  Michele Altomare; Carlo Sposito; Enrico Regalia; Jorgelina Coppa; Maria Flores; Elena Manzo; Michele Droz Dit Busset; Vincenzo Mazzaferro
Journal:  Ann Surg Oncol       Date:  2021-01-22       Impact factor: 5.344

3.  Surgical management of leiomyosarcoma of the inferior vena cava.

Authors:  S W Cho; J W Marsh; D A Geller; M Holtzman; H Zeh; D L Bartlett; T C Gamblin
Journal:  J Gastrointest Surg       Date:  2008-10-08       Impact factor: 3.452

4.  Multidisciplinary treatment and long-term outcomes in six patients with leiomyosarcoma of the inferior vena cava.

Authors:  Jihoon T Kim; Teawon Kwon; Yongpil Cho; Sung Shin; Sunggyu Lee; Deokbog Moon
Journal:  J Korean Surg Soc       Date:  2012-01-27

5.  Leiomyosarcoma of the inferior vena cava.

Authors:  Ben Abid Sadri; Attaoui Mohamed Amine; Mzoughi Zeineb; Miloudi Nizar; Gharbi Lassad; Mohamed Tahar Khalfallah
Journal:  Clin Pract       Date:  2013-05-20

6.  Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection.

Authors:  Frederico José Ribeiro Teixeira; Sergio Dias do Couto Netto; André Luis de Freitas Perina; Fabio C M Torricelli; Luciana Ragazzo Teixeira; Antonio Eduardo Zerati; Fabio de Oliveira Ferreira; Eduardo Hiroshi Akaishi; William Carlos Nahas; Edivaldo Massazo Utiyama
Journal:  Oncol Lett       Date:  2017-08-02       Impact factor: 2.967

Review 7.  Vascular surgery in liver resection.

Authors:  Olga Radulova-Mauersberger; Jürgen Weitz; Carina Riediger
Journal:  Langenbecks Arch Surg       Date:  2021-09-14       Impact factor: 3.445

8.  Surgical management of retroperitoneal leiomyosarcoma arising from the inferior vena cava.

Authors:  Barbara Zarebczan Dull; Brigitte Smith; Girma Tefera; Sharon Weber
Journal:  J Gastrointest Surg       Date:  2013-10-22       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.